The price of the dollar in Venezuela traded above 3.2 million sovereign bolivars over the weekend. Meanwhile, doctors from the Caribbean country asked to review the Cuban vaccine in anticovid tests.
The exchange rate was trading at 3,200,592.80 bolivars per dollar in the parallel or informal market, according to data from the DolarToday platform.
According to the Efe agency, the NGO Médicos Unidos de Venezuela (MUV) asked the government of Nicolás Maduro this Sunday to review its decision to include the Cuban vaccine in Abdala tests. “As a prevention mechanism for COVID-19”, under the argument that it has not yet been authorized by the World Health Organization (WHO).
“We demand that the authorities review their decision to include Abdala as a mechanism for the control and prevention of COVID-19 in Venezuela”, indicated the organization in a statement in which it stressed that the country needs “Vaccines of proven quality, efficiency, efficacy, safety and innocuousness”.
These, the MUV pointed out, are “attributes that Abdala does not yet have, nor does it have the certification of reliable regulatory bodies or authorization from the WHO.”
Venezuela received on Thursday a first batch of the vaccine in the Abdala trial phase, which days ago showed an efficacy of 92.2% in the preliminary results of the third and final stage of studies.
However, the authorities did not detail how many of these drugs against COVID-19 reached the country.